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Radical scavenging activityWe describe here a simple method for the synthesis of glycerol derivatives containing an organochalco-
gen unit (Se, Te and S) using NaBH4 and PEG-400 as a solvent. The new methodology was used to synthe-
size a range of new organochalcogen compounds in good yields. Furthermore, four of synthesized
compounds were evaluated for their antioxidant activity using different assays, such as 2-azinobis-3-eth-
ylbenzothiazoline-6-sulfonic acid (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical, nitric oxide (NO)
and hydroxyl radical (OH) scavenging, ferric ion reducing antioxidant power (FRAP), ferrous ion chelat-
ing, superoxide dismutase-like activity and inhibition of linoleic acid lipid peroxidation. The new organo-
tellurium 2,2-dimethyl-4-(phenyltellanylmethyl)-1,3-dioxolane 3j showed antioxidant activity and was
more effective in inhibition of induced lipid peroxidation compared to solketal 4. Selenium and sulfur
analogs 3a and 3m and solketal 4 did not present antioxidant effect. These ﬁndings suggest that 2,
2-dimethyl-4-(phenyltellanylmethyl)-1,3-dioxolane 3j is a promising antioxidant and that its activity
is inﬂuenced by the presence of the tellurium atom on the structure.
 2014 Elsevier Ltd. All rights reserved.1. Introduction biological activities, with activity in vitro against HIV-1 and HIV-In the last decades, there has been a large interest in identifying
free radical scavengers or antioxidants that can inhibit or retard
the oxidative damage.1 Oxidative stress, induced by the generation
of reactive oxygen species (ROS), is considered a major causative
factor of many of today’s diseases including diabetes, cardiovascu-
lar diseases, cancer and several neurodegenerative diseases such as
Alzheimer’s and Parkinson’s diseases, Down’s syndrome, inﬂam-
mation, viral infection and various digestive disorders.2 Thus, one
of the most important strategies to minimize damage caused by
ROS is the use of dietary antioxidant intake. Despite a large number
of available synthetic antioxidants, they are costly and many of
them are associated to various side effects such as anorexia, nausea
and diarrhea.3 In recent years the increasing interest in the synthe-
sis and pharmacology properties of antioxidants containing organ-
ochalcogens has been documented in a great number of articles,
reviews and books.4,5
Selenoethers containing nucleosides derived from uridine are a
class of organoselenium compounds which have interesting2 in primary lymphocytes.6 Several of these selenoethers were
obtained by nucleophilic substitution of tosyl group in their
corresponding substrates.6,7 Besides, in the total synthesis of the
(+)-SCH 351448 (active in the LDLR assay), the selenoether unit
is present in an intermediate for construction of the 28-membered
macrodiolide structure.7a
Furthermore, we can ﬁnd some reports where these compounds
were used as intermediates for several reactions, for example, the
synthesis of methyl 6,7-dichloro-2,3-dihydrobenzo[b]furan-2-car-
boxylate8 and 2,3-trans-disubstituted cyclopentanones.9 Selenoe-
thers make also part of more complex structures,10 which are
used as building blocks in organic synthesis, including the prepara-
tion of new C-glycosides10b and of ()-massarilactone B,10e a
potent antibacterial agent.
On the other hand, glycerol has been used in a great number of
common applications in cosmetics, pharmaceuticals, food indus-
tries and as a platform for bio-based polymers.11 A key derivative
of glycerol is the tosylate 1 of its acetonide derivative (solketal 4).
This compound was widely used in the preparation of bioactive
lipopeptides,12 spiro heterocycles,13 pheromones,14 glyco-glyceroli-
pids,15 the drug epichlorohydrin,16 new indole-based MK2 inhibi-
tors,17 1,2,4-triazoles inhibitors of brassinosteroid biosynthesis,18
epothilones B and D19 and of a new maleimide, potent inhibitor of
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Scheme 1. General scheme of the present work.
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about the solketal analogues containing organochalcogen.12,15,21
In view of mentioned, and according our interest in the synthe-
sis and biological evaluation of organochalcogen compounds,22 we
report here the results on the synthesis of new glycerol derivatives
containing organochalcogen units using NaBH4/PEG-400 as the
reducing system. Additionally, some of the obtained compounds
were screened for their antioxidant activity in vitro (Scheme 1).2. Materials and methods
2.1. Chemistry
The reactions were monitored by TLC carried out on Merck sil-
ica gel (60 F254) by using UV light as visualizing agent and 5% van-
illin in 10% H2SO4 and heat as developing agents. NMR spectra
were recorded with Bruker DPX 300, DPX 400 and DPX 500 (300,
400 and 500 MHz, respectively) instrument using CDCl3 as solvent
and calibrated using tetramethylsilane as internal standard. Cou-
pling constants (J) are reported in Hertz. Low-resolution mass
spectra were obtained with a Shimadzu GC–MS-QP2010 mass
spectrometer. The key starting material tosylate 1 was synthesized
according previously described.21a
2.1.1. General procedure for the synthesis of chalcogenoethers
To a mixture of dichalcogenide 2 [0.3 mmol of (RY)2], in PEG-
400 (3 mL) under N2 atmosphere, NaBH4 (0.023 g, 0.6 mmol) was
added at room temperature and stirred for 30 min. Then, the tosyl-
ate 1 (0.5 mmol) was added and the temperature was slowly raised
to 50 C and the reaction progress was followed by TLC. After the
time indicated in Table 2, the reaction mixture was washed with
a mixture of hexane/ethyl acetate 98:2 (3  3 mL) and the upper
organic phases were separated from PEG, dried with MgSO4 and
the solvent was evaporated under reduced pressure. The product
was isolated by column chromatography using silica gel 60A
(0.060–0.200 mm-Across) hexane or hexane/ethyl acetate as elu-
ent. The new compounds were fully characterized and the spectral
data are listed below:2.1.1.1. 2,2-Dimethyl-4-(phenylselanylmethyl)-1,3-dioxolane
3a. Yield: 0.128 g (94%); yellowish oil; 1H NMR (500 MHz,
CDCl3); d (ppm): 7.50–7.54 (m, 2H, Ar-H), 7.25–7.28 (m, 3H,
Ar-H), 4.25–4.31 (m, 1H, O–CH), 4.08 (dd, J = 8.4 and 6.0 Hz, 1H,
O–CH2), 3.69 (dd, J = 8.4 and 6.0 Hz, 1H, O–CH2), 3.16 (dd, J = 12.4
and 5.0 Hz, 1H, Se–CH2), 2.93 (dd, J = 12.4 and 8.3 Hz, 1H,
Se–CH2), 1.42 (d, J = 0.5 Hz, 3H, C–CH3), 1.33 (d, J = 0.6 Hz, 3H,
C–CH3). 13C NMR (CDCl3, 100 MHz); d (ppm): 132.9, 129.3, 129.1,
127.2, 109.6, 75.4, 69.3, 30.6, 27.0, 25.6. MS: m/z (rel. int.)
272 (17.0), 157 (11.4), 101 (66.7), 43 (100.0). Anal. Calcd for
C12H16O2Se: C 53.14, H 5.95. Found: C 52.98, H 5.93.2.1.1.2. 2,2-Dimethyl-4-(o-tolylselanylmethyl)-1,3-dioxolane
3b. Yield: 0.137 g (96%); yellowish oil; 1H NMR (CDCl3,
400 MHz); d (ppm): 7.46 (d, J = 7.8 Hz, 1H, Ar-H), 7.07–7.18 (m,
3H, Ar-H), 4.24–4.31 (m, 1H, O–CH), 4.08 (dd, J = 8.3 and 6.1 Hz,
1H, O–CH2), 3.70 (dd, J = 8.3 and 6.1 Hz, 1H, O–CH2), 3.13 (dd,
J = 12.2 and 4.9 Hz, 1H, Se–CH2), 2.89 (dd, J = 12.2 and 8.3 Hz, 1H,
Se–CH2), 2.42 (s, 3H, Ar-CH3), 1.43 (s, 3H, C–CH3), 1.33 (s, 3H,
C–CH3). 13C NMR (CDCl3, 125 MHz); d (ppm): 139.5, 132.0, 130.3,
130.1, 127.1, 126.6, 109.6, 75.2, 69.3, 29.5, 27.0, 25.6, 22.4. MS:
m/z (rel. int.) 286 (22.4), 115 (20.3), 101 (73.7), 91 (58.3), 43
(100.0). Anal. Calcd for C13H18O2Se: C 54.74, H 6.36. Found: C
55.12, H 6.34.
2.1.1.3. 2,2-Dimethyl-4-(p-tolylselanylmethyl)-1,3-dioxolane
3c. Yield: 0.113 g (79%); yellowish oil; 1H NMR (CDCl3,
300 MHz); d (ppm): 7.44–7.40 (m, 2H, Ar-H), 7.09–7.06 (m, 2H,
Ar-H), 4.21–4.30 (m, 1H, O–CH), 4.07 (dd, J = 8.4 and 5.9 Hz, 1H,
O–CH2), 3.67 (dd, J = 8.4 and 6.1 Hz, 1H, O–CH2), 3.12 (dd, J = 12.4
and 4.9 Hz, 1H, Se–CH2), 2.88 (dd, J = 12.4 and 8.4 Hz, 1H, Se–
CH2), 2.32 (s, 3H, Ar-CH3), 1.42 (d, J = 0.5 Hz, 3H, C–CH3), 1.32 (d,
J = 0.6 Hz, 3H, C–CH3). 13C NMR (CDCl3, 75 MHz); d (ppm): 137.4,
133.5, 130.0, 125.4, 109.6, 75.5, 69.3, 30.9, 27.1, 25.7, 21.1. MS:
m/z (rel. int.) 286 (35.0), 115 (29.7), 101 (100.0), 91 (45.0), 43
(92.3). Anal. Calcd for C13H18O2Se: C 54.74, H 6.36. Found: C
54.74, H 6.38.
2.1.1.4. 4-[(2-Methoxyphenylselanyl)methyl]-2,2-dimethyl-1,3-
dioxolane 3d. Yield: 0.130 g (86%); colorless oil; 1H NMR
(CDCl3, 300 MHz); d (ppm): 7.40 (dd, J = 7.6 and 1.6 Hz, 1H, Ar-
H), 7.23 (ddd, J = 8.2, 7.6 and 1.7 Hz 1H, Ar-H), 6.89 (td, J = 7.6
and 1.2 Hz, 2H, Ar-H), 6.84 (dd, J = 8.2 and 1.2 Hz, 2H, Ar-H),
4.25–4.33 (m, 1H, O–CH), 4.09 (dd, J = 8.4 and 5.9 Hz, 1H,
O–CH2), 3.87 (s, 3H, O–CH3), 3.74 (dd, J = 8.4 and 6.0 Hz, 1H,
O–CH2), 3.18 (dd, J = 12.3 and 4.7 Hz, 1H, Se–CH2), 2.89 (dd,
J = 12.3 and 8.8 Hz, 1H, Se–CH2), 1.44 (d, J = 0.3 Hz, 3H, C–CH3),
1.33 (d, J = 0.4 Hz, 3H, C–CH3). 13C NMR (CDCl3, 125 MHz); d
(ppm): 157.9, 131.8, 128.2, 121.4, 118.2, 110.5, 109.5, 75.3, 69.3,
55.8, 27.8, 27.0, 25.6. MS: m/z (rel. int.) 302 (33.0), 101 (81.5), 43
(100.0). Anal. Calcd for C13H18O3Se: C 51.83, H 6.02. Found: C
51.97, H 6.19.
2.1.1.5. 4-[(4-Methoxyphenylselanyl)methyl]-2,2-dimethyl-1,3-
dioxolane 3e. Yield: 0.091 g (60%); yellowish oil; 1H NMR
(CDCl3, 500 MHz); d (ppm): 7.50–7.47 (m, 2H, Ar-H), 6.83–6.80
(m, 2H, Ar-H), 4.20–4.26 (m, 1H, O–CH), 4.07 (dd, J = 8.4 and
6.0 Hz, 1H, O–CH2), 3.79 (s, 3H, O–CH3), 3.65 (dd, J = 8.4 and
6.2 Hz, 1H, O–CH2), 3.06 (dd, J = 12.3 and 5.0 Hz, 1H, Se–CH2),
2.84 (dd, J = 12.3 and 8.4 Hz, 1H, Se–CH2), 1.41 (d, J = 0.5 Hz, 3H,
C–CH3), 1.32 (d, J = 0.6 Hz, 3H, C–CH3). 13C NMR (CDCl3,
125 MHz); d (ppm): 159.5, 135.8, 118.9, 114.8, 109.4, 75.5, 69.2,
55.2, 31.5, 26.9, 25.6. MS: m/z (rel. int.) 302 (48.5), 187 (81.2),
101 (99.4), 43 (100.0). Anal. Calcd for C13H18O3Se: C 51.83, H
6.02. Found: C 51.71, H 6.23.
2.1.1.6. 4-[(4-Fluorophenylselanyl)methyl]-2,2-dimethyl-1,3-
dioxolane 3f. Yield: 0.065 g (45%); yellowish oil; 1H NMR
(CDCl3, 300 MHz); d (ppm): 7.49–7.55 (m, 2H, Ar-H), 6.93–7.01
(m, 2H, Ar-H), 4.21–4.29 (m, 1H, O–CH), 4.08 (dd, J = 8.4 and
6.0 Hz, 1H, O–CH2), 3.67 (dd, J = 8.4 and 6.1 Hz, 1H, O–CH2), 3.10
(dd, J = 12.4 and 5.1 Hz, 1H, Se–CH2), 2.90 (dd, J = 12.4 and 8.0 Hz,
1H, Se–CH2), 1.41 (d, J = 0.5 Hz, 3H, C–CH3), 1.33 (d, J = 0.5 Hz,
3H, C–CH3). 13C NMR (CDCl3, 75 MHz); d (ppm): 162.4 (d,
J = 245.9 Hz), 135.5 (d, J = 7.9 Hz), 123.6 (d, J = 3.5 Hz), 116.3 (d,
J = 21.4 Hz), 109.6, 75.3, 69.2, 31.5, 26.9, 25.5. MS: m/z (rel. int.)
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Figure 1. Chemical structures of solketal (4) and organochalcogen compounds
(3a,j,m).
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H15FO2Se: C 49.84, H 5.23. Found: C 49.94, H 5.23.
2.1.1.7. 2,2-Dimethyl-4-[(3-(triﬂuoromethyl)phenylselanyl)-
methyl]-1,3-dioxolane 3g. Yield: 0.124 g (73%); yellowish
oil; 1H NMR (CDCl3, 500 MHz); d (ppm): 7.79 (s, 1H, Ar-H), 7.69
(d, J = 7.8 Hz, 1H, Ar-H), 7.50 (d, J = 7.9 Hz, 1H, Ar-H), 7.38 (t, 1H,
J = 7.8 Hz, Ar-H), 4.28–4.33 (m, 1H, O–CH), 4.10 (dd, J = 8.4 and
6.0 Hz, 1H, O–CH2), 3.72 (dd, J = 8.4 and 6.0 Hz, 1H, O–CH2), 3.18
(dd, J = 12.5 and 5.4 Hz, 1H, Se–CH2), 3.02 (dd, J = 12.5 and 7.4 Hz,
1H, Se–CH2), 1.42 (d, J = 0.5 Hz, 3H, C–CH3), 1.34 (d, J = 0.6 Hz,
3H, C–CH3). 13C NMR (CDCl3, 100 MHz); d (ppm): 135.7 (q,
J = 1.4 Hz), 131.5 (q, J = 32.2 Hz), 130.9, 129.4, 129.2 (q,
J = 3.9 Hz), 123.9 (q, J = 3.8 Hz), 123.7 (q, J = 271.1 Hz), 109.8,
75.2, 69.2, 31.0, 26.9, 25.5. MS: m/z (rel. int.) 340 (5.0), 101
(54.1), 43 (100.0). Anal. Calcd for C13H15F3O2Se: C 46.03, H 4.46.
Found: C 46.35, H 4.38.
2.1.1.8. 4-(Mesitylselanylmethyl)-2,2-dimethyl-1,3-dioxolane
3h. Yield: 0.063 g (40%); white solid; mp 34–35 C. 1H NMR
(CDCl3, 500 MHz); d (ppm): 6.91 (s, 2H, Ar-H), 4.11–4.16 (m, 1H,
O–CH), 4.03 (dd, J = 8.2 and 6.0 Hz, 1H, O–CH2), 3.63 (dd, J = 8.2
and 6.1 Hz, 1H, O–CH2), 2.87 (dd, J = 12.0 and 5.0 Hz, 1H,
Se–CH2), 2.66 (dd, J = 12.0 and 8.5 Hz, 1H, Se–CH2), 2.52 (s, 6H,
Ar-CH3), 2.24 (s, 3H, Ar-CH3), 1.39 (s, 3H, C–CH3), 1.30 (s, 3H, C–
CH3). 13C NMR (CDCl3, 125 MHz); d (ppm): 142.9, 138.2, 128.5,
126.8, 109.3, 75.7, 69.3, 30.3, 27.0, 25.5, 24.3, 20.8. MS: m/z (rel.
int.) 314 (21.0), 199 (28.9), 119 (100.0), 101 (54.4), 43 (66.2). Anal.
Calcd for C15H22O2Se: C 57.51, H 7.08. Found: C 57.58, H 7.02.
2.1.1.9. 4-(Butylselanylmethyl)-2,2-dimethyl-1,3-dioxolane 3i.
Yield: 0.096 g (76%); yellowish oil; 1H NMR (CDCl3, 300 MHz); d
(ppm): 4.25–4.34 (m, 1H, O–CH), 4.14 (dd, J = 8.2 and 6.0 Hz, 1H,
O–CH2), 3.70 (dd, J = 8.2 and 6.4 Hz, 1H, O–CH2), 2.79 (dd, J = 12.4
and 5.2 Hz, 1H, CH2–Se–Bu), 2.61 (dd, J = 12.4 and 7.9 Hz, 1H,
CH2–Se–Bu), 2.58–2.65 (m, 2H, Se–CH2–CH2), 1.62–1.69 (m, 2H,
Se–CH2–CH2–CH2), 1.34–1.46 (m, 2H, Se–CH2–CH2–CH2CH3), 1.44
(d, J = 0.5 Hz, 3H, C–CH3), 1.36 (d, J = 0.5 Hz, 3H, C–CH3), 0.92 (t,
J = 7.4 Hz, 3H, Se–CH2–CH2–CH2CH3). 13C NMR (CDCl3, 75 MHz); d
(ppm): 109.6, 76.0, 69.5, 32.6, 27.0, 26.4, 25.7, 24.5, 22.9, 13.6.
MS: m/z (rel. int.) 252 (11.6), 101 (56.6), 43 (100.0). Anal. Calcd
for C10H20O2Se: C 47.81, H 8.02. Found: C 46.66, H 7.84.
2.1.1.10. 2,2-Dimethyl-4-(phenyltellanylmethyl)-1,3-dioxolane
3j. Yield: 0.145 g (90%); reddish oil; 1H NMR (CDCl3,
500 MHz); d (ppm): 7.74–7.76 (m, 2H, Ar-H), 7.27–7.30 (m, 1H,
Ar-H), 7.18–7.22 (m, 2H, Ar-H), 4.33–4.38 (m, 1H, O–CH), 4.11
(dd, J = 8.3 and 5.9 Hz, 1H, O–CH2), 3.61 (dd, J = 8.3 and 6.5 Hz,
1H, O–CH2), 3.14 (dd, J = 11.9 and 5.0 Hz, 1H, Te–CH2), 2.98 (dd,
J = 11.9 and 8.2 Hz, 1H, Te–CH2), 1.42 (d, J = 0.6 Hz, 3H, C–CH3),
1.33 (d, J = 0.6 Hz, 3H, C–CH3). 13C NMR (CDCl3, 75 MHz); d
(ppm): 138.5, 129.2, 127.8, 110.9, 109.6, 76.6, 70.3, 27.1, 25.7,
11.9. MS: m/z (rel. int.) 322 (29.3), 115 (74.8), 101 (26.3), 77
(98.7), 43 (100.0). Anal. Calcd for C12H16O2Te: C 45.06, H 5.04.
Found: C 45.30, H 5.10.
2.1.1.11. 2,2-Dimethyl-4-(p-tolyltellanylmethyl)-1,3-dioxolane
3k. Yield: 0.118 g (70%); orange solid; mp 44–46 C. 1H
NMR (CDCl3, 300 MHz); d (ppm): 7.66–7.62 (m, 2H, Ar-H), 7.03–
7.00 (m, 2H, Ar-H), 4.29–4.38 (m, 1H, O–CH), 4.10 (dd, J = 8.3 and
5.9 Hz, 1H, O–CH2), 3.58 (dd, J = 8.3 and 6.6 Hz, 1H, O–CH2), 3.10
(dd, J = 11.9 and 5.0 Hz, 1H, Te–CH2), 2.92 (dd, J = 11.9 and
8.3 Hz, 1H, Te–CH2), 2.33 (s, 3H, Ar-CH3), 1.41 (d, J = 0.5 Hz, 3H,
C–CH3), 1.32 (d, J = 0.6 Hz, 3H, C–CH3).13C NMR (CDCl3, 75 MHz);
d (ppm): 139.0, 138.0, 130.2, 109.6, 106.7, 76.6, 70.3, 27.1, 25.7,
21.2, 11.8. MS: m/z (rel. int.) 336 (36.3), 221 (44.4), 115 (71.7),101 (19.4), 91 (100.0), 43 (56.9). Anal. Calcd for C13H18O2Te: C
46.77, H 5.43. Found: C 46.85, H 5.50.
2.1.1.12. 4-[(4-Chlorophenyltellanyl)methyl]2,2-dimethyl-1,3-
dioxolane 3l. Yield: 0.139 g (78%); yellowish solid; mp
38–39 C. 1H NMR (CDCl3, 300 MHz); d (ppm): 7.68–7.64 (m, 2H,
Ar-H), 7.19–7.15 (m, 2H, Ar-H), 4.30–4.38 (m, 1H, O–CH), 4.10
(dd, J = 8.3 and 6.0 Hz, 1H, O–CH2), 3.60 (dd, J = 8.3 and 6.5 Hz,
1H, O–CH2), 3.12 (dd, J = 12.0 and 5.2 Hz, 1H, Te–CH2), 2.99 (dd,
J = 12.0 and 7.7 Hz, 1H, Te–CH2), 1.42 (d, J = 0.5 Hz, 3H, C–CH3),
1.33 (d, J = 0.6 Hz, 3H, C–CH3). 13C NMR (75 MHz, CDCl3); d
(ppm): 140.0, 134.5, 129.5, 109.7, 108.5, 76.4, 70.3, 27.0, 25.7,
12.5. MS: m/z (rel. int.) 356 (33.6), 241 (57.9), 115 (100.0), 101
(40.7), 57 (83.7), 43 (81.0). Anal. Calcd for C12H15FO2Te: C 40.68,
H 4.27. Found: C 41.09, H 4.39.
2.1.1.13. 2,2-Dimethyl-4-(phenylthiomethyl)-1,3-dioxolane
3m:23. Yield: 0.0896 g (80%), yellowish oil; 1H NMR (CDCl3,
300 MHz); d (ppm): 7.36–7.38 (m, 2H, Ar-H), 7.25–7.30 (m, 2H,
Ar-H), 7.18–7.22 (m, 1H, Ar-H), 4.21–4.26 (m, 1H, O–CH), 4.08
(dd, J = 8.5 and 6.0 Hz, 1H, O–CH2), 3.75 (dd, J = 8.5 and 5.8 Hz,
1H, O–CH2), 3.22 (dd, J = 13.4 and 4.9 Hz, 1H, S–CH2), 2.95 (dd,
J = 13.4 and 8.2 Hz, 1H, S–CH2), 1.43 (d, J = 0.5 Hz, 3H, C–CH3),
1.33 (d, J = 0.6 Hz, 3H, C–CH3). 13C NMR (CDCl3, 75 MHz); d
(ppm): 135.4, 129.7, 129.1, 126.5, 109.7, 74.7, 68.8, 37.2, 27.0,
25.5. MS: m/z (rel. int.) 224 (35.3), 209 (15.7), 101 (100.0), 43
(89.8).
2.2. Biological assays
2.2.1. Antioxidant activity
The antioxidant activities of compounds 3a, 3l, 3o and 4 (Fig. 1)
were evaluated by the following in vitro assays: 2,2-azinobis-3-
ethylbenzothiazoline-6-sulfonic acid (ABTS) and 2,2-diphenyl-1-
picrylhydrazyl (DPPH) radical scavenging activity, nitric oxide
(NO) scavenging, hydroxyl radical (OH.) scavenging, ferric ion
reducing antioxidant power (FRAP), ferrous ion chelating, superox-
ide dismutase-like activity and inhibition of linoleic acid lipid
peroxidation.
2.2.2. Radical scavenging activity
The stable radical DPPH has been widely used for determining
the hydrogen- or electron-donating capacity of pure antioxidant
compounds, plant and fruit extracts and foodmaterials.24 The DPPH
radical is a stable free radical that is commonly used as a substrate
to evaluate in vitro antioxidant activity. The scavenging activity of
compounds (10–500 lM) was determined in accordance with the
method of Choi and co-workers25 with some modiﬁcations.
The ABTS method is based on the ability of antioxidants to
quench the long-lived ABTS radical cation, a blue/green chromo-
phore with characteristic absorption at 734 nm. The ABTS radical
scavenging activity was determined according to the method
described by Re et al.26 with some modiﬁcations. Different concen-
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solution, and the decrease in the absorbance at 734 nm was
recorded.
The hydroxyl radical scavenging activities were determined
according to the method described by Smirnoff et al.27 with some
modiﬁcations. Sodium nitroprusside (SNP) is an inorganic complex
in which NO exists as NO+; light irradiation is necessary for the
release of NO.28 To estimate the possible NO-scavenging activity
of compounds (10–500 lM), SNP (25 mM) was incubated alone
or in combination with compounds. The NO-scavenging effect
was measured according to the method of Marcocci et al.29 with
a slight modiﬁcation. The absorbance was determined at 570 nm
and referred to the absorbance of standard solutions of sodium
nitrite salt previously treated with Griess reagent.
The radical scavenging activity, expressed as percent inhibition
(% I) in relation to the control values was calculated according to
the following equation:
% I ¼ ½1 ðAs  AcÞ=Ac  100;
where Ac is absorbance of the control (without compounds) and As
is the absorbance in the presence of compounds.
2.2.3. Ferric ion reducing antioxidant power (FRAP)
The ferric ion (Fe3+) reducing antioxidant power (FRAP) method
was used to measure the reducing power of synthesized com-
pounds. The assay was carried out as described by Stratil et al.30
with slight modiﬁcations. Different concentrations of compounds
(5–500 lM) and FRAP reagent (FeCl3, triazine and sodium acetate
buffer pH 3.2; 10:1:1) were added to each sample, and the mixture
was incubated at 37 C for 40 min in the dark. The absorbance of
the resulting solution was measured at 593 nm.
2.2.4. Superoxide dismutase (SOD)-like activity
Molecules that mimic SOD are interesting in the point of view of
antioxidant activity by inactivation of superoxide anion radical
(O2).31 Consequently, compounds with SOD-like activity are con-
siderate an important tool to prevention and treatment of many
diseases related to oxidative stress.31 Thus, SOD-like activity of
compounds (10–500 lM) was determined as described by Markl-
und and Marklund.31b Brieﬂy, Tris–HCl buffer (pH 8.5) and
24 mM pyrogallol were added to the sample solution during
60 min at 37 C. Sample activities are expressed as the auto-oxida-
tion inhibition rate (%) of pyrogallol vs. the control sample (sample
without compounds).
2.2.5. Linoleic acid peroxidation assay
The total lipid peroxidation was estimated by the measurement
of malondialdehyde (MDA) levels, which are an end product of
lipid peroxidation. The MDA level was determined spectrophoto-Table 1
Optimization of the synthesis of 3aa
O OTs
O
1 2a
Se
Se+
Entry 2a (mmol) NaBH4 (mmol) Solvent
1 0.25 0.30 Ethanol
2 0.25 0.30 Ethanol
3 0.25 0.30 PEG-40
4 0.25 0.30 PEG-40
5 0.25 0.50 PEG-40
6 0.30 0.60 PEG-40
a Reactions performed by stirring a mixture of 1 (0.5 mmol), 2a, NaBH4 and solvent (
b Yields are given for isolated product 3a.metrically by the thiobarbituric acid reactive substances (TBARS)
assay. In this assay, linoleic acid was used as a lipid matrix to eval-
uate the effect of compounds on Fe2+, ascorbic acid-induced lipid
peroxidation. The ability of compounds (10–500 lM) to inhibit lin-
oleic acid peroxidation was determined by the method of Choi
et al.25 with modiﬁcations. The absorbance of the organic phase
was measured at 532 nm using n-butanol as blank.
2.2.6. Statistical analysis
The results as means ± standard deviation (SD) for the experi-
ments data were performed using one-way analysis of variance fol-
lowed by Newman–Keuls’ test when appropriated. All tests were
performed at least three times in duplicate. The IC50 values (con-
centration of sample required to scavenger 50% free radical or to
prevent lipid peroxidation by 50%) were calculated from the graph-
ical of scavenging effect percentage against compounds concentra-
tion. The p values less than 0.05 (p <0.05) were considered as
indicative of signiﬁcance.3. Results and discussion
3.1. Chemistry
Our initial studies were focused on the development of an opti-
mum set of nucleophilic displacement reaction of tosyl group with
chalcogenolate anions. To determine the best conditions, initially
the tosylate 1 (0.5 mmol) was reacted with diphenyl diselenide 2a
(0.25 mmol) in the presence of NaBH4 under N2 atmosphere
(Table 1). It was evaluated the inﬂuence of temperature and the nat-
ure of the solvent and it was found that using ethanol (3.0 mL) and
NaBH4 (0.30 mmol) at room temperature, unsatisfactory yield of the
product 3awas obtained and a great amount of diphenyl diselenide
was recovered (Table 1, entry 1). When a mixture of ethanol/THF
(50:50) was used, a small increase in the yield of 3a was observed
after 24 h (Table 1, entry 2).
Recently, PEG has been used as an alternative promising solvent
in organic synthesis,32 including the synthesis of 3-hydroxy-3-
(pyridine-2-ylmethyl)indolin-2-ones,32a trisubstituted thiophene
analogues of 1-thiazolyl-2-pyrazoline32b and in cycloaddition,32h
N-arylation32g and cross-coupling reactions.32c,f In this sense, our
group described the in situ generation of chalcogenolate anion by
using the system PEG/NaBH4/(RY)2 (Y = Se, Te).33 More recently,
these nucleophilic species were successfully added to bis-chalcogeno
alkenes34 and a,b-unsaturated ketones, esters, acid and nitrile.35
Thus, when PEG-400 was used as solvent, the desired product
3a was obtained in 27% yield after 24 h (Table 1, entry 3). To our
satisfaction, increasing the temperature to 50 C, 3a was obtained
in 59% yield after 4 h (Table 1, entry 4). Aiming to improve the yieldNaBH4, solvent
temperature, N2
O Se
O
3a
Temp (C) Time (h) Yieldb (%)
rt 24 5
/THF rt 24 12
0 rt 24 27
0 50 4 59
0 50 4 85
0 50 4 94
3.0 mL) under N2 atmosphere.
Table 2
Scope and generality of the synthesis of compounds 3a–ma
O OTs
O PEG-400, NaBH4
50 ºC, N2
O YR
O
RYYR
1 2a-m 3a-m
+
Entry Dichalcogenide Product Time (h) Yieldb (%)
1
2a
Se
Se O Se
O
3a
4 94
2
2b
Se
Se O Se
O
3b
4 96
3
2c
Se
Se O Se
O
3c
6 79
4
2d
Se
Se
H3CO
OCH3
O Se
O
3d
CH3O
4 86
5
2e
Se
Se
OCH3
H3CO
O Se
O
OCH3
3e
8 71
6
2f
Se
Se
F
F
O Se
O
F
3f
6 80
7
2g
Se
Se
CF3
CF3
O Se
O
3g
CF3
5 73
8
2h
Se
Se O Se
O
3h
10 40
9 2i
Se
Se
O Se
O
3i
3 76
10
2j
Te
Te O Te
O
3j
6 90
11
2k
Te
Te O Te
O
3k
5 70
12
2l
Te
Te
Cl
Cl
O Te
O
Cl
3l
6 78
13
2m
S
S O S
O
3m
4 80
a Reactions are performed in the presence of tosylate 1 (0.5 mmol), dichalcogenide 2a–m (0.3 mmol) and NaBH4 (0.6 mmol) at 50 C under N2 atmosphere.
b Yields are given for isolated products.
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raised to 85% (Table 1, entry 5). It was observed that a slight excess
of diphenyl diselenide 2a was necessary to complete consume of
tosylate 1, yielding the desired product 3a in 94% after 4 h (Table 1,
entry 6).To extend the scope of our methodology, the possibility of per-
forming the reaction with other aryl and alkyl dichalcogenides was
investigated (Table 2). As can be seem in Table 2, diaryl diselenides
containing electron-donating and electron-withdrawing groups
reacted successfully with 1, affording high yields of the respective
Table 3
DPPH radical scavenging of synthesized compounds
Concd (lM) Compounds
4 3m 3a 3j
10 0.54 ± 0.94 0.01 ± 0.00 0.98 ± 1.70 3.57 ± 3.10
50 0.98 ± 1.70 1.07 ± 1.20 0.63 ± 1.00 11.08 ± 6.10
100 0.98 ± 1.70 0.50 ± 0.50 0.63 ± 1.00 22.55 ± 0.80⁄⁄
500 0.98 ± 1.07 1.65 ± 1.90 1.30 ± 1.10 77.86 ± 13.40⁄⁄⁄
IC50 — — — 308.60 ± 53.70
The values are expressed in percentage of inhibition by the compound compared to
the control Data are represented as mean ± SD. IC50 = concentration required of
compound for 50% scavenging. The asterisks represent signiﬁcant difference (⁄⁄) p
<0.01; (⁄⁄⁄) p <0.001 when compared with control sample by Student–Newman–
Keuls test for post-hoc comparison.
Table 4
ABTS radical scavenging of synthesized compounds
Concd (lM) Compounds
4 3m 3a 3j
1 nt nt nt 2.18 ± 3.20
5 nt nt nt 12.04 ± 5.80
10 0.0 0.47 ± 0.30 0.0 22.72 ± 7.9⁄⁄
25 0.0 0.0 0.0 53.41 ± 2.80⁄⁄⁄
50 0.85 ± 1.20 0.15 ± 0.16 1.19 ± 1.30 90.64 ± 16.50⁄⁄⁄
100 1.70 ± 2.40 0.36 ± 0.30 1.15 ± 1.10 99.50 ± 0.80⁄⁄⁄
500 9.84 ± 12.70 0.08 ± 0.15 4.75 ± 4.10 99.90 ± 0.00⁄⁄⁄
IC50 — — — 24.50 ± 2.50
The values are expressed in percentage of inhibition in relation to control (DMSO).
Data are represented as mean ± SD. The asterisks represent signiﬁcant difference
(⁄⁄) p <0.01; (⁄⁄⁄) p <0.001 when compared with control sample by Student–New-
man–Keuls test for post-hoc comparison. nt: not tested.
Table 5
Nitric oxide scavenging of compounds
Concd (lM) Compounds
4 3m 3a 3j
10 56.60 ± 11.54 49.59 ± 13.81 54.43 ± 15.54 64.13 ± 10.16
50 55.45 ± 8.77 50.91 ± 15.28 52.50 ± 15.28 55.95 ± 3.94
100 52.22 ± 8.91 50.48 ± 15.50 51.95 ± 12.90 54.93 ± 5.82
500 54.47 ± 15.15 49.68 ± 15.47 49.65 ± 14.99 44.49 ± 7.78⁄
Data expressed as mean ± SD of NaNO2 concentration (lM). The asterisks represent
signiﬁcant difference (⁄) p <0.05 when compared to control sample (without com-
pounds) by Student–Newman–Keuls test for post-hoc comparison.
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However, when the sterically hindered dimesityl diselenide 2h
was used, only 40% yield of the respective selenoether 3h was iso-
lated, even after 10 h of reaction (Table 2, entry 8). To our satisfac-
tion, the reaction with dibutyl diselenide 2i gave the product 3i in
76% yield, showing the applicability of the method also for dialkyl
diselenides (Table 2, entry 9).Table 6
Ferric ion reducing antioxidant power (FRAP) of synthesized compounds
Sample
Control
Compounds (lM) 4 3m
10 0.08 ± 0.00 0.08 ±
50 0.08 ± 0.00 0.08 ±
100 0.08 ± 0.00 0.08 ±
500 0.09 ± 0.00 0.11 ±
Data expressed mean ± SD. The asterisks represent signiﬁcant difference (⁄⁄) p <0.01; (⁄⁄⁄)
by Student–Newman–Keuls test for post-hoc comparison.3.2. Biological assays
3.2.1. Radical scavenging activity
In order to verify the inﬂuence of the chalcogenium atom in the
biological activity of synthesized molecules, the antioxidant activ-
ity of compounds 3a, 3j, 3m and the solketal 4 (Fig. 1) was evalu-
ated by different assays in vitro (Tables 3 and 4).
As can be seen in Tables 3 and 4, the compound containing tel-
lurium (3j) demonstrated to be effective in both DPPH and ABTS+
radical scavenging activities, with IC50 values (sample concentra-
tion required to inhibit 50% of the radicals) of 308.60 ± 53.70 lM
and 24.50 ± 2.50 lM, respectively. Despite there is no known bio-
logical function for tellurium compounds in biology, the glutathi-
one peroxidase-like activity of diaryl tellurides has been
described.4b,j Compounds 3a, 3m and 4 did not present IC50
because they did not inhibit 50% of the ABTS+ and DDPH. The val-
ues of maximum inhibition (Imax) in both DPPH and ABTS followed
the order 3j>3a = 3m = 4.
Assays based upon the use of DPPH and ABTS radicals are
among the most widespread spectrophotometric methods for the
determination of antioxidant capacity,36 as both chromogens and
radical compounds can directly react with antioxidants.
The DPPH assay is based on an electron transfer reaction and
hydrogen-atom abstraction, reﬂecting the reducing ability of
tested compounds toward DPPH.37 The ABTS assay is mainly based
on a single electron transfer, and the reduction of ABTS+ radical
cation can be more efﬁcient than of DPPH.38 In this study, our
results revealed that compound 3j (with presence of Te on the
structure) presented higher radical scavenging efﬁciency in the
DPPH and ABTS+ assays compared to the other tested compounds.
The IC50 values on the DPPH (308.60 lM) and ABTS (24.50 lM)
assays indicate that compound 3j is more potent in the ABTS assay,
suggesting that the mechanism of antioxidant activity is probably
based on single electron transfer.
It is important to highlight that modiﬁcations in the nature of
the organochalgenium compound (Se, S or O instead Te) remark-
ably inﬂuenced in the radical-scavenging ability. Thus, none or very
low activity was observed for the selenium and thio analogs 3a and
3m and solketal 4 in the tested concentrations (Tables 3 and 4).
In the NO-scavenging assay, compound 3j at 500 lM reduced
the production of nitrite, indicating its potential as a NO-scaveng-
ing agent. In contrast, analog compounds 3a, 3m and 4 did not
present this effect (Table 5). None of the tested compounds pre-
sented hydroxyl radical scavenging activity at tested concentra-
tions (data not show).
3.2.2. Ferric ion reducing antioxidant power (FRAP)
Reports have demonstrated that the reducing power might be
strongly correlated with the antioxidant activity of a given
compound.39 Thus, based on this evidence, the FRAP assaywas used
to determine the reducing power of synthesized compounds to elu-
cidate the relationship between the antioxidant effect and the
reducing power. Compound 3j exhibited ferric-reducing ability,Absorbance at 593 nm
0.07 ± 0.00
3a 3j
0.00 0.08 ± 0.10 0.33 ± 0.00
0.00 0.10 ± 0.10 1.06 ± 0.20⁄⁄
0.00 0.12 ± 0.00 1.57 ± 0.50⁄⁄⁄
0.00 0.18 ± 0.00 2.00 ± 0.00⁄⁄⁄
p <0.001 when compared with control sample (FRAP solution without compounds)
Table 7
Effect of compounds against Fe2+–ascorbic acid induced lipid oxidation of linoleic acid system
Sample Lipid peroxidation (%)
Control 50.52 ± 22.50
Fe2+–AA 100
Compounds (lM) 4 3m 3a 3j
1 72.67 ± 25.50 86.70 ± 26.60 88.37 ± 16.40 79.46 ± 29.90
5 66.2 ± 23.10 87.79 ± 24.40 94.34 ± 8.00 66.29 ± 20.00
10 79.89 ± 22.10 76.51 ± 21.40 86.97 ± 11.20 57.39 ± 21.30⁄
50 72.35 ± 17.00 76.51 ± 21.40 89.97 ± 11.10 43.34 ± 22.30⁄⁄
100 72.48 ± 22.20 74.88 ± 18.20 86.55 ± 11.80 31.66 ± 11.90⁄⁄⁄
500 76.4 ± 20.40 72.46 ± 22.20 81.22 ± 13.80 20.60 ± 9.40⁄⁄⁄
IC50 — — — 24.50 ± 2.50
Data expressed mean ± SD of lipid peroxidation sample. (⁄) p <0.05; (⁄⁄) p <0.01; (⁄⁄⁄) p <0.001 when compared with Fe2+–ascorbic acid (pro-oxidants) by Student–Newman–
Keuls test for post-hoc comparison.
Table 8
IC50 values of tested compounds
Assay 4 3m 3a 3j
DPPH scavenging activity ns ns ns 308.60 ± 53.7
ABTS+ scavenging activity ns ns ns 24.50 ± 2.5
Linoleic acid peroxidation ns ns ns 24.50 ± 2.5
ns: not signiﬁcant; compounds did not show appreciable antioxidant activity.
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tion (Table 6). On the other hand, the compounds 3a, 3m and 4 did
not presented ferric ion reducing antioxidant power. This result
is in agreement with the ﬁndings from the ABTS assay and
conﬁrms that the antioxidant power of 3j can be due to electron
transfer.
3.2.3. Superoxide dismutase (SOD)-like activity
Since compounds tested did not present SOD-like activity (data
not show), indicating that this mechanism is not involved in the
antioxidant activity of 3j.3.2.4. Linoleic acid peroxidation assay
Lipid peroxidation can be deﬁned as the oxidative deterioration
of lipids containing carbon–carbon double bonds. In biological sys-
tems, lipid peroxidation is considered a toxicological phenomenon
that can lead to various pathological consequences. Oxidation of
linoleic acid generates linoleic acid hydroperoxides, which decom-
pose to secondary oxidation products. In this method, the MDA
formed after linoleic oxidation was measured by TBARS method
and the values are presented in Table 7. According the results,
compound 3j was the most potent, with the IC50 value of
24.50 ± 2.50 lM. Other synthesized chalcogen compounds (3a,
3m and 4) did not present IC50 because they did not inhibit 50%
of the lipid peroxidation.
Table 8 summarizes the antioxidant activity of tested com-
pounds 4, 3m, 3a and 3j according IC50 values. As can be seen only
compound 3j shown signiﬁcant IC50 values. These ﬁndings are in
agreement with several reports in the literature, in which tellu-
rium-containing compounds have shown to be very effective anti-
oxidant agents, even more than their sulfur and selenium
analogues.40 Thus, based on the results obtained we believe that
our work will ﬁnd an important application in the synthesis of
organochalcogen compounds derivatives of glycerol to fulﬁll the
needs of academia as well as pharmaceutical industries.
4. Conclusion
In summary, by using the system (RY)2/NaBH4/PEG to generate
the nucleophilic species of chalcogenium, several Se, S and Te-func-tionalized adducts derivatives from glycerol were easily and selec-
tively obtained. By this new protocol, a range of chalcogenoethers
was obtained from aliphatic and functionalized diaryl dichalcoge-
nides in good yields. Moreover, 2,2-dimethyl-4-(phenyltellanylm-
ethyl)-1,3-dioxolane (3j) is a promising antioxidant, and we can
infer that the antioxidant activity of this chalcogenoether is related
to the presence of the tellurium atom in the structure. Studies
using 3j in more complex and physiologically relevant systems
are necessary to improve the knowledge regarding its exact antiox-
idant mechanism.
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